Skip to search formSkip to main contentSkip to account menu

quinaprilat

Known as: (3S)-2-((S)-N-((S)-1-Carboxy-3-Phenylpropyl)Alanyl)-1,2,3,4-Tetrahydro-3-Isoquinolinecarboxylic Acid, 2-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 3-Isoquinolinecarboxylic Acid, 2-(2-((1-Carboxy-3-Phenylpropyl)Amino)-1-Oxopropyl)-1,2,3,4-Tetrahydro-, (3S-(2(R*(R*)),3R*))- 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

Angiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsTetrahydroisoquinolines

Narrower (1)

CI 928
Hydrochlorothiazide 12.5 MG / quinapril 10 MG Oral Tabletquinapril 10 MG Oral Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury.
Review
2006
Review
2006
Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells
Abstract Carboxypeptidase cleavage of the C-terminal Arg of kinins generates specific agonists of the B1 receptor. Activation of… 
2003
2003
Inhibition study of angiotensin converting enzyme by capillary electrophoresis after enzymatic reaction at capillary inlet.
Highly Cited
2001
Highly Cited
2001
Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade
Abstract—ACE inhibitors block B2 receptor desensitization, thereby potentiating bradykinin beyond blocking its hydrolysis… 
2001
2001
High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
Highly Cited
1999
Highly Cited
1999
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.
BACKGROUND Endothelial cells (ECs) represent the critical cellular element responsible for postnatal angiogenesis. Because ACE… 
1997
1997
Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
The beneficial therapeutic effects of angiotensin-converting enzyme (ACE) inhibitors are the result of reduced angiotensin II… 
Highly Cited
1996
Highly Cited
1996
Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth.
Mesangial cell growth and accumulation of extracellular matrix proteins constitute key features of progressive glomerular injury… 
Highly Cited
1994
Highly Cited
1994
Release of nitric oxide by angiotensin‐(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor
The angiotensin I (AI) metabolite, A(1–7), elicited a concentration‐dependent dilator response (ED50 ≥ 2 μm) in porcine coronary… 
Review
1992
Review
1992
Comparative pharmacokinetics of captopril, enalapril, and quinapril.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)